Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat

Go back to Kala Pharmaceuticals (KALA) Reports In-Line Q1 EPS, Revenues Beat
(NASDAQ: KALA) Delayed: 3.54 -0.07 (1.94%)
Previous Close $3.61    52 Week High
Open $3.69    52 Week Low
Day High $3.71    P/E N/A 
Day Low $3.22    EPS
Volume 142,026